Ledger.Open graph →
SEC Form D · filed September 12, 2018

SEngine Precision Medicine, Inc

Offering
$13.6M
Sold
$720K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Ashoat Tevosyan · New York, NYExecAndrew S. Gazdecki · San Mateo, CAExec · Director · PromoterTim Kiefer · Munsbach, LuxembourgDirectorThomas D. Kenneally · Schenectady, NYDirectorTobias Peggs · Brooklyn, NYExecGeorge Matelich · Brooklyn, NYExec · Director · PromoterChristopher Kemp · Seattle, WAExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗